A Family Affair: Hereditary Breast Cancer and You
As someone with a history of breast cancer, you may worry your genes played a part in the disease, and if they did, what it might mean for the future health of you or your family members. While only 5-10 percent of breast cancers are thought to be hereditary – caused by abnormal genes passed from mother or father to child – there is a lot to understand about the role genes play in your health, breast cancer risk and treatment options. Most hereditary breast cancers are related to mutations in the BRCA1 and BRCA2 genes, but more gene mutations are being studied every day.
Join Living Beyond Breast Cancer and Triple Negative Breast Cancer Foundation to learn about hereditary breast cancer, who it affects, how it connects to certain subtypes, like triple-negative disease, genetic testing and what to do if you have a family history of cancer. Our panelists will discuss the decision to be tested or not and how to start the conversation with your providers and family members.
Susan M. Domchek, MD
Susan M. Domchek, MD is the Basser Professor in Oncology at the Perelman School of Medicine of the University of Pennsylvania. She serves as executive director of the Basser Center for BRCA at the Abramson Cancer Center and director of the Mariann and Robert MacDonald Cancer Risk Evaluation Center, which focuses on genetic evaluation and medical management of people with inherited risk factors for cancer. Dr. Domchek is a member of both Living Beyond Breast Cancer's and Triple Negative Breast Cancer Foundation's respective Medical Advisory Boards. Read more.
Amy is a certified public accountant and a 10-year breast cancer survivor as well as a 3-time melanoma survivor. She had genetic testing shortly after her stage IIIC breast cancer diagnosis because both her father and her paternal grandmother also had breast cancer. The tests showed that Amy has the BRCA2 genetic mutation, which led her to choose further surgeries to prevent cancer and to have family discussions to make decisions related to the mutation.
Felicia is a retired healthcare professional who prepped surgical cases. Felicia was diagnosed in 2003 with stage IV HER2-positive disease to the lung and sternum, and in 2010 with a primary early-stage triple-negative breast cancer. She has not had genetic testing but she is considering it. She has 11 women in her family who have had breast cancer, as well as one who has been diagnosed with both breast and ovarian cancer. As a result of such an extensive family history of cancer and her own diagnosis, she has become a community advocate, blogger and speaker.
You can attend this free event in person or by live web stream. The program will begin at 6:00 p.m. (ET). For those attending in person, registration and refreshments will begin at 5:30 p.m. (ET).
This interactive event will feature a panel discussion followed by a Q&A session. Both in-person and web stream audiences will be able to text their questions to the moderator during the Q&A session. For questions or to register by phone call toll-free (855) 807-6386.